CALGARY, AB – CanadaBis Capital, a cannabis and concentrates producer, reported its first-auarter fiscal 2025 financial results for the three-month period ending April 30, 2025.
Despite a challenging market environment, the Company is pleased to report an adjusted EBITDA of positive $440,665 for Q3 2025, demonstrating resilience and operational efficiency.
Travis McIntyre, CEO of CanadaBis Capital, stated, “Our ability to achieve positive EBITDA in this challenging market is a testament to our team’s dedication and our strategic focus on cost management and product innovation. The successful launch of our diamond and Keef-coated pre-rolls not only showcases our commitment to quality but also our responsiveness to market trends. The improvement in gross profit as a percentage of revenue reflects our operational efficiency. As we prepare to introduce our revolutionary vape hardware later this year, we look forward to re-establishing Stigma Grow’s presence in the vape market with our innovative and high-quality offerings. As we continue to reduce our debt and optimize our operations, we are well-positioned for future growth.”
Financial Highlights
Gross Revenue: CanadaBis achieved gross revenue of $5.5 million for Q3 2025, reflecting a strategic decision to delist marginally profitable SKUs from provincial boards amid seasonally weak cannabis sales.
Gross Revenue and Net Income Insights
Efficiency Improvement: Gross profit as a percentage of gross revenue increased by 6%, indicating a significant enhancement in operating efficiency during this period.
Cost Savings: The Company successfully reduced Selling, General and Administrative expenses (SG&A) to $1.4 million, a significant decrease of 30% from $1.8 million in the same period last year. This cost control initiative has been crucial in maintaining positive EBITDA levels.
Adjusted EBITDA: Despite the decrease in revenue, adjusted EBITDA remained robust at $440,665, staying on track with comparative quarters with higher gross revenue showing that cost cutting measures and optimization strategies are working giving way for larger up side in future periods.
Debt Reduction: CanadaBis has made significant strides in improving its financial health by reducing its short-term debt by $2.5 million during the quarter.
Product Launch: The Company successfully launched its new line of 50’s diamond and Keef-coated pre-rolls, which have been sold out multiple times throughout the later part of the quarter, underscoring strong market demand.
Liquidity Position: In early April 2025, CanadaBis closed a brokered private placement, raising gross proceeds of $4,035,000 from the issuance of 4,035 unsecured 11% convertible debentures. This financing has strengthened the Company’s short-term liquidity, positioning it for strategic growth opportunities.
Operational Focus
CanadaBis continues to focus on optimizing its operations through input and manufacturing cost control, SKU rationalization, and effective inventory management. The total SKU count in the Company’s three largest provinces has been reduced to 83 as of April 30, 2025, from 111 as of January 31, 2025.
The Company is now evaluating opportunities to expand its offerings in flower sales and licensing its brands internationally, in addition to bulk extract sales through business-to-business channels domestically.
About CanadaBis Capital Inc.
CanadaBis Capital Inc. (TSXV: CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the global cannabis market producing high-quality cannabis products and building a portfolio of trusted brands. CanadaBis is committed to delivering value to shareholders and exploring innovative pathways for growth.
Related Articles:
